Haruna Shimagaki

9PUBLICATIONS
31CO-AUTHORS
Molecular targetsSocial epidemiologyMajor global burdens of diseaseMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 30, 2025
Inhibition of formyl peptide receptor-1-mediated cell death as a therapy for lethal cutaneous drug reactions in preclinical models.

Haruna Kimura, Akito Hasegawa, Tomoki Nishiguchi

|Jul 14, 2025
Efficacy and Safety of Etanercept in Japanese Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Unresponsive to Systemic Steroid Therapy: A Multicenter, Open-Label, Single-Arm Study.

Haruna Kimura, Mahoko Oginezawa, Natsumi Hama

|Oct 16, 2024
Spatial proteomics identifies JAKi as treatment for a lethal skin disease.

Thierry M Nordmann, Holly Anderton, Akito Hasegawa

|Mar 17, 2020
Case of cutaneous botryomycosis in an 8-year-old immunocompetent boy with a review of the published work.

Haruna Shimagaki, Akihiko Yuki, Kiyoto Kimura

Pageof 2

Frequent Collaborators

4 joint publications

Riichiro Abe

3 joint publications

Akito Hasegawa

2 joint publications

Natsumi Hama

1 joint publications

Yukie Umemori